Merck Co Inc (MRK)

Sep 03, 2025

Veterinary Oncology Market Shares, Competition and Trends Analysis 2025-2030: Discover the Impact of Advanced Therapies and Digital Tools - GlobeNewswire Inc.

Sep 03, 2025

Sep 02, 2025

Merck Taps US Investment-Grade Bond Market for Verona Purchase - Bloomberg.com

Sep 02, 2025

Sep 02, 2025

Merck's cholesterol drug gets a boost with another late-stage trial success - Reuters

Sep 02, 2025

Sep 02, 2025

What's Going On With Merck Stock Tuesday?Merck & Co (NYSE:MRK) - Benzinga

Sep 02, 2025

Sep 02, 2025

Merck's Portfolio and Solid Late-Stage Pipeline Defend Against Upcoming Keytruda Headwinds - Morningstar

Sep 02, 2025

Sep 02, 2025

Leerink Partners Remains Bullish on Merck & Co. (MRK) - MSN

Sep 02, 2025

Sep 02, 2025

No Spoils For VICTOR As Bayer/Merck & Co’s Verquvo Fails Phase III Trial - insights.citeline.com

Sep 02, 2025

Sep 02, 2025

Merck to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference - PharmiWeb.com

Sep 02, 2025

Sep 02, 2025

Merck succeeds in late-stage trial for cholesterol drug - Seeking Alpha

Sep 02, 2025

Sep 02, 2025

First-Ever Oral PCSK9 Drug Success: Merck's Enlicitide Shows Breakthrough in Cholesterol Treatment - Stock Titan

Sep 02, 2025

Sep 02, 2025

Merck & Co., Inc. (MRK) Launches $3B Plan to Reinvest Ahead of Keytruda Patent Expiry in 2028 - Yahoo Finance

Sep 02, 2025

Sep 02, 2025

Merck & Co. Inc. (MRK) Initiates Phase 3 Trial on Breast Cancer Drug - MSN

Sep 02, 2025

Sep 01, 2025

Animal Health Market Trends, Key Player Strategies, and Growth Outlook to 2034 - GlobeNewswire Inc.

Sep 01, 2025

Aug 31, 2025

Co. Inc.Trade Ideas & Safe Swing Trade Setup Alerts - Newser

Aug 31, 2025

Aug 31, 2025

Merck & Co. (MRK) Announces First Patient Dosage in HERTHENA-Breast04 Phase 3 Trial - Yahoo Finance

Aug 31, 2025

Aug 30, 2025

Merck Provides New Results for VERQUVO® (vericiguat) in Patients with Chronic Heart Failure and Reduced Ejection Fraction - FinancialContent

Aug 30, 2025

Aug 29, 2025

Is Merck Stock Outperforming the Dow? - MSN

Aug 29, 2025

Aug 28, 2025

Merck (MRK) Up 2.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Aug 28, 2025

Aug 28, 2025

Merck to Participate in the 2025 Wells Fargo Healthcare Conference - PharmiWeb.com

Aug 28, 2025

Aug 28, 2025

2025 Wells Fargo Healthcare Conference - Merck.com

Aug 28, 2025

Aug 28, 2025

Merck & Co., Inc. (MRK) Expands Targeted Therapy Pipeline with ADC Advances - Insider Monkey

Aug 28, 2025

Aug 27, 2025

Elfun Trusts Exits Merck & Co Inc, Impacting Portfolio by -1.85% in Q2 2025 - AInvest

Aug 27, 2025

Aug 27, 2025

Elfun Trusts Exits Merck & Co Inc, Impacting Portfolio by -1.85% - Yahoo Finance

Aug 27, 2025

Aug 27, 2025

Summit, Akeso Lung Cancer Drug Rivals Merck’s KeytrudaSummit Therapeutics (NASDAQ:SMMT) - Benzinga

Aug 27, 2025

Aug 26, 2025

Rising as One, Shining as Many - GlobeNewswire Inc.

Aug 26, 2025

Aug 25, 2025

Merck & Co., Inc. shares fall 1.73% intraday after Bernstein reiterates Neutral rating, lowering target price to EUR 138. - AInvest

Aug 25, 2025

Aug 25, 2025

Merck Demonstrates Ongoing Commitment to Advancing Cardiovascular Disease Management and Patient Care with New Data at the European Society of Cardiology Congress 2025 - The Globe and Mail

Aug 25, 2025

Aug 21, 2025

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Aug 21, 2025

Aug 20, 2025

Merck shares snapped six-session winning streak (NYSE:MRK) - Seeking Alpha

Aug 20, 2025

Aug 20, 2025

Merck & Co Inc (MRK) Highlights Gaps in Flea and Tick Prevention Adherence - AInvest

Aug 20, 2025

Aug 19, 2025

Skyhawk’s small-molecule RNA efforts draw Merck KGaA in $2B deal - BioWorld MedTech

Aug 19, 2025

Aug 19, 2025

Vets and Pet-Owners See Gaps in Flea and Tick Prevention, Highlighting Need for Year-Round Care, New Merck Animal Health Global Survey Finds - Business Wire

Aug 19, 2025

Aug 19, 2025

Merck & Co., Inc. shares rise 1.71% intraday after FDA grants Breakthrough Therapy Designation to Ifinatamab Deruxtecan for small cell lung cancer. - AInvest

Aug 19, 2025

Aug 18, 2025

Skyhawk Flies High With Another Big Pharma, Getting Up To $2bn In Merck KGaA Deal - insights.citeline.com

Aug 18, 2025

Aug 18, 2025

Merck KGaA Signs $2 Billion Neurology Drug Pact With Skyhawk - Bloomberg.com

Aug 18, 2025

Aug 18, 2025

Merck: Shares Bucking The Gardasil Problem, Hiking My Price Target - Seeking Alpha

Aug 18, 2025

Aug 18, 2025

Q3 EPS Estimates for Merck & Co., Inc. Cut by Zacks Research - Defense World

Aug 18, 2025

Aug 18, 2025

Janux Therapeutics Receives $10M Milestone Payment from Merck for Advancing Cancer Therapy Collaboration - MSN

Aug 18, 2025

Aug 17, 2025

Merck & Co., Inc. (MRK) Announces Update on Phase 3 KEYNOTE-905 Trial - MSN

Aug 17, 2025

Aug 16, 2025

Merck Stock: Buy The Weakness (NYSE:MRK) - Seeking Alpha

Aug 16, 2025

Aug 16, 2025

Austria Accepts Merck Commitments After ‘Predatory Pricing’ Undermined Generics - insights.citeline.com

Aug 16, 2025

Aug 16, 2025

Merck & Co., Inc. (MRK) Impresses Jim Cramer With Its Toughness - MSN

Aug 16, 2025

Aug 15, 2025

The Zacks Analyst Blog Highlights Merck, Palo Alto Networks, Freeport-McMoRan and Espey - Yahoo Finance

Aug 15, 2025

Aug 14, 2025

Top Analyst Reports for Merck, Palo Alto & Freeport - Yahoo Finance

Aug 14, 2025

Aug 14, 2025

10 Stocks Jim Cramer Discussed As He Questioned Official Data - Insider Monkey

Aug 14, 2025